Report Detail

Request for Sample of this report

Pharma & Healthcare Global H1 Receptor Antagonist Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

  • RnM4551177
    • |
  • 22 August, 2023
    • |
  • Global
    • |
  • 118 Pages
    • |
  • GIR (Global Info Research)
    • |
  • Pharma & Healthcare

According to our (Global Info Research) latest study, the global H1 Receptor Antagonist market size was valued at USD 35700 million in 2022 and is forecast to a readjusted size of USD 58730 million by 2029 with a CAGR of 7.4% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
H1 receptor antagonists (H1 receptor antagonists, referred to as H1RAS) prevent histamine from acting on target cells by reversibly competing for histamine receptor sites on cells, and play a role by blocking and antagonizing H1 receptors. Anti-allergic effect, in order to prevent a series of physiological reactions from happening.
This report is a detailed and comprehensive analysis for global H1 Receptor Antagonist market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global H1 Receptor Antagonist market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global H1 Receptor Antagonist market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global H1 Receptor Antagonist market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global H1 Receptor Antagonist market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2018-2023.
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for H1 Receptor Antagonist
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace.
This report profiles key players in the global H1 Receptor Antagonist market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Teva, Bayer, Pfizer, LETI and Novartis, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
H1 Receptor Antagonist market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
First Generation H1RAS
Second-generation H1RAS
Third-generation H1RAS
Market segment by Application
Hospital
Retail Pharmacy
Other
Major players covered
Teva
Bayer
Pfizer
LETI
Novartis
Hypera Pharma
Woodward
Merck
Johnson and Johnson
Ethical pharma
Gems pharma
KPL Pharma
GlaxoSmithKline
Ying Yuan
Schering-Plough
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe H1 Receptor Antagonist product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of H1 Receptor Antagonist, with price, sales, revenue and global market share of H1 Receptor Antagonist from 2018 to 2023.
Chapter 3, the H1 Receptor Antagonist competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the H1 Receptor Antagonist breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and H1 Receptor Antagonist market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of H1 Receptor Antagonist.
Chapter 14 and 15, to describe H1 Receptor Antagonist sales channel, distributors, customers, research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope of H1 Receptor Antagonist
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global H1 Receptor Antagonist Consumption Value by Type: 2018 Versus 2022 Versus 2029
    • 1.3.2 First Generation H1RAS
    • 1.3.3 Second-generation H1RAS
    • 1.3.4 Third-generation H1RAS
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global H1 Receptor Antagonist Consumption Value by Application: 2018 Versus 2022 Versus 2029
    • 1.4.2 Hospital
    • 1.4.3 Retail Pharmacy
    • 1.4.4 Other
  • 1.5 Global H1 Receptor Antagonist Market Size & Forecast
    • 1.5.1 Global H1 Receptor Antagonist Consumption Value (2018 & 2022 & 2029)
    • 1.5.2 Global H1 Receptor Antagonist Sales Quantity (2018-2029)
    • 1.5.3 Global H1 Receptor Antagonist Average Price (2018-2029)

2 Manufacturers Profiles

  • 2.1 Teva
    • 2.1.1 Teva Details
    • 2.1.2 Teva Major Business
    • 2.1.3 Teva H1 Receptor Antagonist Product and Services
    • 2.1.4 Teva H1 Receptor Antagonist Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.1.5 Teva Recent Developments/Updates
  • 2.2 Bayer
    • 2.2.1 Bayer Details
    • 2.2.2 Bayer Major Business
    • 2.2.3 Bayer H1 Receptor Antagonist Product and Services
    • 2.2.4 Bayer H1 Receptor Antagonist Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.2.5 Bayer Recent Developments/Updates
  • 2.3 Pfizer
    • 2.3.1 Pfizer Details
    • 2.3.2 Pfizer Major Business
    • 2.3.3 Pfizer H1 Receptor Antagonist Product and Services
    • 2.3.4 Pfizer H1 Receptor Antagonist Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.3.5 Pfizer Recent Developments/Updates
  • 2.4 LETI
    • 2.4.1 LETI Details
    • 2.4.2 LETI Major Business
    • 2.4.3 LETI H1 Receptor Antagonist Product and Services
    • 2.4.4 LETI H1 Receptor Antagonist Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.4.5 LETI Recent Developments/Updates
  • 2.5 Novartis
    • 2.5.1 Novartis Details
    • 2.5.2 Novartis Major Business
    • 2.5.3 Novartis H1 Receptor Antagonist Product and Services
    • 2.5.4 Novartis H1 Receptor Antagonist Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.5.5 Novartis Recent Developments/Updates
  • 2.6 Hypera Pharma
    • 2.6.1 Hypera Pharma Details
    • 2.6.2 Hypera Pharma Major Business
    • 2.6.3 Hypera Pharma H1 Receptor Antagonist Product and Services
    • 2.6.4 Hypera Pharma H1 Receptor Antagonist Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.6.5 Hypera Pharma Recent Developments/Updates
  • 2.7 Woodward
    • 2.7.1 Woodward Details
    • 2.7.2 Woodward Major Business
    • 2.7.3 Woodward H1 Receptor Antagonist Product and Services
    • 2.7.4 Woodward H1 Receptor Antagonist Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.7.5 Woodward Recent Developments/Updates
  • 2.8 Merck
    • 2.8.1 Merck Details
    • 2.8.2 Merck Major Business
    • 2.8.3 Merck H1 Receptor Antagonist Product and Services
    • 2.8.4 Merck H1 Receptor Antagonist Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.8.5 Merck Recent Developments/Updates
  • 2.9 Johnson and Johnson
    • 2.9.1 Johnson and Johnson Details
    • 2.9.2 Johnson and Johnson Major Business
    • 2.9.3 Johnson and Johnson H1 Receptor Antagonist Product and Services
    • 2.9.4 Johnson and Johnson H1 Receptor Antagonist Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.9.5 Johnson and Johnson Recent Developments/Updates
  • 2.10 Ethical pharma
    • 2.10.1 Ethical pharma Details
    • 2.10.2 Ethical pharma Major Business
    • 2.10.3 Ethical pharma H1 Receptor Antagonist Product and Services
    • 2.10.4 Ethical pharma H1 Receptor Antagonist Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.10.5 Ethical pharma Recent Developments/Updates
  • 2.11 Gems pharma
    • 2.11.1 Gems pharma Details
    • 2.11.2 Gems pharma Major Business
    • 2.11.3 Gems pharma H1 Receptor Antagonist Product and Services
    • 2.11.4 Gems pharma H1 Receptor Antagonist Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.11.5 Gems pharma Recent Developments/Updates
  • 2.12 KPL Pharma
    • 2.12.1 KPL Pharma Details
    • 2.12.2 KPL Pharma Major Business
    • 2.12.3 KPL Pharma H1 Receptor Antagonist Product and Services
    • 2.12.4 KPL Pharma H1 Receptor Antagonist Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.12.5 KPL Pharma Recent Developments/Updates
  • 2.13 GlaxoSmithKline
    • 2.13.1 GlaxoSmithKline Details
    • 2.13.2 GlaxoSmithKline Major Business
    • 2.13.3 GlaxoSmithKline H1 Receptor Antagonist Product and Services
    • 2.13.4 GlaxoSmithKline H1 Receptor Antagonist Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.13.5 GlaxoSmithKline Recent Developments/Updates
  • 2.14 Ying Yuan
    • 2.14.1 Ying Yuan Details
    • 2.14.2 Ying Yuan Major Business
    • 2.14.3 Ying Yuan H1 Receptor Antagonist Product and Services
    • 2.14.4 Ying Yuan H1 Receptor Antagonist Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.14.5 Ying Yuan Recent Developments/Updates
  • 2.15 Schering-Plough
    • 2.15.1 Schering-Plough Details
    • 2.15.2 Schering-Plough Major Business
    • 2.15.3 Schering-Plough H1 Receptor Antagonist Product and Services
    • 2.15.4 Schering-Plough H1 Receptor Antagonist Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.15.5 Schering-Plough Recent Developments/Updates

3 Competitive Environment: H1 Receptor Antagonist by Manufacturer

  • 3.1 Global H1 Receptor Antagonist Sales Quantity by Manufacturer (2018-2023)
  • 3.2 Global H1 Receptor Antagonist Revenue by Manufacturer (2018-2023)
  • 3.3 Global H1 Receptor Antagonist Average Price by Manufacturer (2018-2023)
  • 3.4 Market Share Analysis (2022)
    • 3.4.1 Producer Shipments of H1 Receptor Antagonist by Manufacturer Revenue ($MM) and Market Share (%): 2022
    • 3.4.2 Top 3 H1 Receptor Antagonist Manufacturer Market Share in 2022
    • 3.4.2 Top 6 H1 Receptor Antagonist Manufacturer Market Share in 2022
  • 3.5 H1 Receptor Antagonist Market: Overall Company Footprint Analysis
    • 3.5.1 H1 Receptor Antagonist Market: Region Footprint
    • 3.5.2 H1 Receptor Antagonist Market: Company Product Type Footprint
    • 3.5.3 H1 Receptor Antagonist Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global H1 Receptor Antagonist Market Size by Region
    • 4.1.1 Global H1 Receptor Antagonist Sales Quantity by Region (2018-2029)
    • 4.1.2 Global H1 Receptor Antagonist Consumption Value by Region (2018-2029)
    • 4.1.3 Global H1 Receptor Antagonist Average Price by Region (2018-2029)
  • 4.2 North America H1 Receptor Antagonist Consumption Value (2018-2029)
  • 4.3 Europe H1 Receptor Antagonist Consumption Value (2018-2029)
  • 4.4 Asia-Pacific H1 Receptor Antagonist Consumption Value (2018-2029)
  • 4.5 South America H1 Receptor Antagonist Consumption Value (2018-2029)
  • 4.6 Middle East and Africa H1 Receptor Antagonist Consumption Value (2018-2029)

5 Market Segment by Type

  • 5.1 Global H1 Receptor Antagonist Sales Quantity by Type (2018-2029)
  • 5.2 Global H1 Receptor Antagonist Consumption Value by Type (2018-2029)
  • 5.3 Global H1 Receptor Antagonist Average Price by Type (2018-2029)

6 Market Segment by Application

  • 6.1 Global H1 Receptor Antagonist Sales Quantity by Application (2018-2029)
  • 6.2 Global H1 Receptor Antagonist Consumption Value by Application (2018-2029)
  • 6.3 Global H1 Receptor Antagonist Average Price by Application (2018-2029)

7 North America

  • 7.1 North America H1 Receptor Antagonist Sales Quantity by Type (2018-2029)
  • 7.2 North America H1 Receptor Antagonist Sales Quantity by Application (2018-2029)
  • 7.3 North America H1 Receptor Antagonist Market Size by Country
    • 7.3.1 North America H1 Receptor Antagonist Sales Quantity by Country (2018-2029)
    • 7.3.2 North America H1 Receptor Antagonist Consumption Value by Country (2018-2029)
    • 7.3.3 United States Market Size and Forecast (2018-2029)
    • 7.3.4 Canada Market Size and Forecast (2018-2029)
    • 7.3.5 Mexico Market Size and Forecast (2018-2029)

8 Europe

  • 8.1 Europe H1 Receptor Antagonist Sales Quantity by Type (2018-2029)
  • 8.2 Europe H1 Receptor Antagonist Sales Quantity by Application (2018-2029)
  • 8.3 Europe H1 Receptor Antagonist Market Size by Country
    • 8.3.1 Europe H1 Receptor Antagonist Sales Quantity by Country (2018-2029)
    • 8.3.2 Europe H1 Receptor Antagonist Consumption Value by Country (2018-2029)
    • 8.3.3 Germany Market Size and Forecast (2018-2029)
    • 8.3.4 France Market Size and Forecast (2018-2029)
    • 8.3.5 United Kingdom Market Size and Forecast (2018-2029)
    • 8.3.6 Russia Market Size and Forecast (2018-2029)
    • 8.3.7 Italy Market Size and Forecast (2018-2029)

9 Asia-Pacific

  • 9.1 Asia-Pacific H1 Receptor Antagonist Sales Quantity by Type (2018-2029)
  • 9.2 Asia-Pacific H1 Receptor Antagonist Sales Quantity by Application (2018-2029)
  • 9.3 Asia-Pacific H1 Receptor Antagonist Market Size by Region
    • 9.3.1 Asia-Pacific H1 Receptor Antagonist Sales Quantity by Region (2018-2029)
    • 9.3.2 Asia-Pacific H1 Receptor Antagonist Consumption Value by Region (2018-2029)
    • 9.3.3 China Market Size and Forecast (2018-2029)
    • 9.3.4 Japan Market Size and Forecast (2018-2029)
    • 9.3.5 Korea Market Size and Forecast (2018-2029)
    • 9.3.6 India Market Size and Forecast (2018-2029)
    • 9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
    • 9.3.8 Australia Market Size and Forecast (2018-2029)

10 South America

  • 10.1 South America H1 Receptor Antagonist Sales Quantity by Type (2018-2029)
  • 10.2 South America H1 Receptor Antagonist Sales Quantity by Application (2018-2029)
  • 10.3 South America H1 Receptor Antagonist Market Size by Country
    • 10.3.1 South America H1 Receptor Antagonist Sales Quantity by Country (2018-2029)
    • 10.3.2 South America H1 Receptor Antagonist Consumption Value by Country (2018-2029)
    • 10.3.3 Brazil Market Size and Forecast (2018-2029)
    • 10.3.4 Argentina Market Size and Forecast (2018-2029)

11 Middle East & Africa

  • 11.1 Middle East & Africa H1 Receptor Antagonist Sales Quantity by Type (2018-2029)
  • 11.2 Middle East & Africa H1 Receptor Antagonist Sales Quantity by Application (2018-2029)
  • 11.3 Middle East & Africa H1 Receptor Antagonist Market Size by Country
    • 11.3.1 Middle East & Africa H1 Receptor Antagonist Sales Quantity by Country (2018-2029)
    • 11.3.2 Middle East & Africa H1 Receptor Antagonist Consumption Value by Country (2018-2029)
    • 11.3.3 Turkey Market Size and Forecast (2018-2029)
    • 11.3.4 Egypt Market Size and Forecast (2018-2029)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
    • 11.3.6 South Africa Market Size and Forecast (2018-2029)

12 Market Dynamics

  • 12.1 H1 Receptor Antagonist Market Drivers
  • 12.2 H1 Receptor Antagonist Market Restraints
  • 12.3 H1 Receptor Antagonist Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry
  • 12.5 Influence of COVID-19 and Russia-Ukraine War
    • 12.5.1 Influence of COVID-19
    • 12.5.2 Influence of Russia-Ukraine War

13 Raw Material and Industry Chain

  • 13.1 Raw Material of H1 Receptor Antagonist and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of H1 Receptor Antagonist
  • 13.3 H1 Receptor Antagonist Production Process
  • 13.4 H1 Receptor Antagonist Industrial Chain

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 H1 Receptor Antagonist Typical Distributors
  • 14.3 H1 Receptor Antagonist Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on H1 Receptor Antagonist. Industry analysis & Market Report on H1 Receptor Antagonist is a syndicated market report, published as Global H1 Receptor Antagonist Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029. It is complete Research Study and Industry Analysis of H1 Receptor Antagonist market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,480.00
    		$5,220.00
    		$6,960.00
    		2,742.24
    		4,113.36
    		5,484.48
    		3,201.60
    		4,802.40
    		6,403.20
    		542,149.20
    		813,223.80
    		1,084,298.40
    		290,092.80
    		435,139.20
    		580,185.60
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo